HealthDay - THURSDAY, March 18 (HealthDay News) -- A review of research on gene expression-based prognostic signatures in lung cancer contends that the signatures aren't ready for prime time.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.